SUMO-1 modification of MEF2A regulates its transcriptional activity

被引:40
作者
Riquelme, Cecilia [1 ]
Barthel, Kristen K. B. [1 ]
Liu, Xuedong [1 ]
机构
[1] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA
关键词
MEF2A; SUMO; PIAS; sumoylation; transcription;
D O I
10.1111/j.1582-4934.2006.tb00295.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Myocyte enhancer factor 2 (MEF2) transcription factors are crucial regulators controlling muscle-specific and growth factor-inducible genes. Numerous studies have reported that the activity of these transcription factors is tightly modulated by posttranslational modifications such as activation by specific phosphorylation as well as repression by class II histone deacetylases (HDACs). We hypothesized that MEF2 could also be regulated by covalent modification by SUMO-1, a reversible posttranslational modification which has been shown to regulate key proteins involved in cell proliferation, differentiation and tumor suppression. In this study, we demonstrate that MEF2A undergoes sumoylation primarily at a single lysine residue (K395) both in vitro and in vivo. We also show that the nuclear E3 ligase, PIAS1, promotes sumoylation of MEF2A. Mutation of lysine 395 to arginine abolishes MEF2A sumoylation and the surnoylation incompetent mutant protein has enhanced transcriptional activity compared to the wild type protein. Our results suggest that protein sumoylation could play a pivotal role in controlling MEF2 transcriptional activity.
引用
收藏
页码:132 / 144
页数:13
相关论文
共 43 条
[21]   The Ulp1 SUMO isopeptidase: distinct domains required for viability, nuclear envelope localization, and substrate specificity [J].
Li, SJ ;
Hochstrasser, M .
JOURNAL OF CELL BIOLOGY, 2003, 160 (07) :1069-1081
[22]   Activation of transforming growth factor-β signaling by SUMO-1 modification of tumor suppressor Smad4/DPC4 [J].
Lin, X ;
Liang, M ;
Liang, YY ;
Brunicardi, FC ;
Melchior, F ;
Feng, XH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (21) :18714-18719
[23]   Serum response factor is modulated by the SUMO-1 conjugation system [J].
Matsuzaki, K ;
Minami, T ;
Tojo, M ;
Honda, Y ;
Uchimura, Y ;
Saitoh, H ;
Yasuda, H ;
Nagahiro, S ;
Saya, H ;
Nakao, M .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 306 (01) :32-38
[24]   SUMO - Nonclassical ubiquitin [J].
Melchior, F .
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, 2000, 16 :591-+
[25]   SUMO: ligases, isopeptidases and nuclear pores [J].
Melchior, F ;
Schergaut, M ;
Pichler, A .
TRENDS IN BIOCHEMICAL SCIENCES, 2003, 28 (11) :612-618
[26]   Role of MADS box proteins and their cofactors in combinatorial control of gene expression and cell development [J].
Messenguy, F ;
Dubois, E .
GENE, 2003, 316 :1-21
[27]   Combinatorial control of muscle development by basic helix-loop-helix and MADS-box transcription factors [J].
Molkentin, JD ;
Olson, EN .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (18) :9366-9373
[28]   SUMO:: a regulator of gene expression and genome integrity [J].
Müller, S ;
Ledl, A ;
Schmidt, D .
ONCOGENE, 2004, 23 (11) :1998-2008
[29]   Conjugation with the ubiquitin-related modifier SUMO-1 regulates the partitioning of PML within the nucleus [J].
Müller, S ;
Matunis, MJ ;
Dejean, A .
EMBO JOURNAL, 1998, 17 (01) :61-70
[30]   Sumo, ubiquitin's mysterious cousin [J].
Müller, S ;
Hoege, C ;
Pyrowolakis, G ;
Jentsch, S .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2001, 2 (03) :202-210